文献速递心律失常

房颤家族史与房颤发病及结局的关联:一项基于人群的家族队列研究

Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study.
PubMed 文献 · JAMA Cardiol · 2017-01-01

结果显示一级亲属患房颤者房颤相对风险为1.92(95%CI 1.84-1.99),遗传因素解释19.9%表型方差,共享环境因素3.5%,非共享环境因素76.6%;匹配后有无家族史的房颤患者MACE无事件生存相似。

要点

  • 房颤一级亲属者房颤相对风险为1.92(95%CI 1.84-1.99)。
  • 遗传因素解释19.9%房颤表型方差,非共享环境因素占76.6%。
  • 有房颤家族史的房颤患者MACE无事件生存与无家族史者相似。

核心结论

  • 遗传和环境因素均与房颤相关,非共享环境因素解释约四分之三的表型方差。
  • 有房颤一级亲属的房颤患者并未出现更多MACE,家族史对房颤诊断或管理的提示作用可能有限。

研究设计与样本

  • 从上述患者中选取2000至2010年新诊断房颤且有房颤一级亲属者,按1:4匹配无家族史对照以估计MACE无事件生存。

主要发现

  • 共1510例新诊断房颤患者有房颤一级亲属,其中204例(13.5%)为女性,平均(SD)年龄57.9(9.2)岁。
  • 房颤一级亲属者房颤相对风险为1.92(95%CI 1.84-1.99)。
  • 房颤表型方差中遗传因素占19.9%,共享环境因素占3.5%,非共享环境因素占76.6%。
  • 按年龄、性别、高血压、2型糖尿病、既往卒中和抗凝匹配后,有与无房颤一级亲属的新发房颤患者MACE无事件生存相似。

临床怎么用

  • 一级亲属有房颤者房颤风险约升高至1.92倍,可据此识别高风险个体。
  • 房颤患者即使一级亲属有房颤,MACE风险未见增加,家族史不宜作为分层管理依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The heritability of atrial fibrillation (AF), the contribution of genetic and environmental factors, and the association of a family history of AF with prognosis are unclear. OBJECTIVES: To measure genetic and environmental factors in the familial aggregation of AF and to estimate the association of a family history of AF with major adverse cardiovascular events (MACE). DESIGN, SETTING, AND PARTICIPANTS: In this Taiwanese nationwide population-based study among more than 23 million people, a custom data set was obtained using the data of all patients having a diagnosis of AF recorded between January 1996 and December 2013 in the Taiwan National Health Insurance Research Database. The study population comprised all 23 422 955 individuals registered with the database in 2013, of whom 177 770 had a diagnosis of AF and were included in the heritability estimation. From the latter, a subgroup of patients having newly diagnosed AF with a first-degree relative affected by AF between 2000 and 2010 were selected and matched 1:4 to controls without a family history for estimating MACE-free survival. The dates of analysis were January 2010 to December 2013. MAIN OUTCOMES AND MEASURES: The prevalence and relative risk of AF in relatives of patients with AF, as well as the relative contributions of heritability and shared and nonshared environmental factors to AF susceptibility. Also measured was MACE-free survival after AF was diagnosed. RESULTS: In total, 1510 patients (204 [13.5%] female; mean [SD] age, 57.9 [9.2] years) had newly diagnosed AF with a first-degree relative affected by AF. Individuals with a first-degree relative affected by AF had a relative risk of 1.92 (95% CI, 1.84-1.99) for AF. The accountability for the phenotypic variance of AF was 19.9% for genetic factors (heritability), 3.5% for shared environmental factors, and 76.6% for nonshared environmental factors. After matching for age, sex, hypertension, type 2 diabetes, previous stroke, and anticoagulation, incident AF patients with vs without an affected first-degree relative had similar MACE-free survival. CONCLUSIONS AND RELEVANCE: Genetic and environmental factors were associated with AF, with nonshared environmental factors accounting for three-fourths of the phenotypic variance in Taiwan. Patients having AF with a first-degree relative affected by AF did not have more MACE. Therefore, family history may not be particularly informative in the diagnosis or management of AF.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Chang SH, Kuo CF, Chou IJ, et al. Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study. JAMA Cardiol. 2017. PMID: 28678986. doi:10.1001/jamacardio.2017.1855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。